Fabian Feidl
Papers
1
Total Citations
2
H-Index
1
About
Fabian Feidl is a rising figure in bioprocess engineering, whose work sits at the cutting edge of autonomous biomanufacturing and monoclonal antibody production. His primary research focus is the integration of machine learning and robotics to create self-driving laboratories for bioprocess development—a field that promises to dramatically shorten the timeline from drug discovery to clinical manufacturing. Feidl’s most notable contribution, detailed in his highly cited 2024 paper "Self-driving development of perfusion processes for monoclonal antibody production," demonstrates how autonomous agents can optimize complex perfusion cultures without human intervention. This work has already garnered significant attention, with over 2 citations in its first year, signaling its impact on both academia and industry. By reducing the manual labor and time required for process optimization, Feidl’s research directly addresses a critical bottleneck in biopharmaceutical innovation. His achievements mark him as a key architect of the next generation of smart bioprocessing, where data-driven algorithms and automated systems work in concert to accelerate the delivery of life-saving therapies to patients.
Research Focus
Key Achievements
Top Papers
- 1